Niacin Increases HDL by Reducing Hepatic Expression and Plasma Levels of Cholesteryl Ester Transfer Protein in APOE*3Leiden.CETP Mice

Open Access Niacin Modulates Pro-inflammatory Cytokine Secretion. A Potential Mechanism Involved in its Anti-atherosclerotic Effect

Pedro Saul Lipszyca
Graciela Alicia Cremaschib
María Zorrilla Zubiletea
Maria Laura Aón
Francisco Capanic
Ana Maria Genaroa
Miriam Ruth Walda

October 2016

Abstract: The pathogenesis of atherosclerosis includes the assignment of a critical role to cells of...

APOE*3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome

Hoek, A.M. van den
Hoorn, J.W.A. van der
Maas, A.C.
Hoogen, R.M. van den
Nieuwkoop, A. van
Droog, S.
Offerman, E.H.
Pieterman, E.J.
Havekes, L.M.
Princen, H.M.G.

January 2014

Aims: This study aimed to investigate systematically (i) the appropriate dietary conditions to induc...

Niacin: Does It affect 8-hydroxy-2-deoxyguanosine levels of the patients having low HDL cholesterol levels?

Ece Harman
Serkan Akcay
Yanki Buke
Hakan Er

June 2013

We aimed to determine whether niacin improve plasma HDL-cholesterol levels by decreasing 8-Hydroxyde...

Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice

van der Hoorn, José W A
de Haan, Willeke
Berbée, Jimmy F P
Havekes, Louis M
Jukema, J Wouter
Rensen, Patrick C N
Princen, Hans M G

November 2008

Niacin potently decreases plasma triglycerides and LDL-cholesterol. In addition, niacin is the most ...

Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice

Li, Z.
Wang, Y.
Sluis, R.J. van der
Hoorn, J.W.A. van der
Princen, H.M.G.
Eck, M. van
Berkel, T.J.C. van
Rensen, P.C.N.
Hoekstra, M.

January 2012

The anti-dyslipidemic drug niacin has recently been shown to reduce the hepatic expression and plasm...

Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol

Kühnast Susan
Louwe Mieke C.
Heemskerk Mattijs M.
Pieterman Elsbet J.
van Klinken Jan B.
van den Berg Sjoerd A. A.
Smit Johannes W. A.
Havekes Louis M.
Rensen Patrick C. N.
van der Hoorn José W. A.
Princen Hans M. G.
Jukema J. Wouter

June 2013

Niacin potently lowers triglycerides, mildly decreases LDL-cholesterol, and largely increases HDL-ch...

Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-

Mieke C. Louwe
Mattijs M. Heemskerk
Elsbet J. Pieterman
Jan B. Van
Johannes W. A. Smit
Louis M. Havekes
Patrick C. N. Rensen
Hans M. G. Princen
J. Wouter Jukema

August 2016

Objective: Niacin potently lowers triglycerides, mildly decreases LDL-cholesterol, and largely incre...

Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol.

Susan Kühnast
Mieke C Louwe
Mattijs M Heemskerk
Elsbet J Pieterman
Jan B van Klinken
Sjoerd A A van den Berg
Johannes W A Smit
Louis M Havekes
Patrick C N Rensen
José W A van der Hoorn
Hans M G Princen
J Wouter Jukema

Niacin potently lowers triglycerides, mildly decreases LDL-cholesterol, and largely increases HDL-ch...

Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice

de Haan, Willeke
van der Hoogt, Caroline C
Westerterp, Marit
Hoekstra, Menno
Dallinga-Thie, Geesje M
Princen, Hans M G
Romijn, Johannes A
Jukema, J Wouter
Havekes, Louis M
Rensen, Patrick C N

March 2008

In addition to lowering low-density lipoprotein (LDL)-cholesterol, statins modestly increase high-de...

Niacin Increases Adiponectin and Decreases Adipose Tissue Inflammation in High Fat Diet-Fed Mice

Wanders Desiree
Graff Emily C.
White B. Douglas
Judd Robert L.

August 2013

To determine the effects of niacin on adiponectin and markers of adipose tissue inflammation in a mo...

Niacin increases adiponectin and decreases adipose tissue inflammation in high fat diet-fed mice.

Desiree Wanders
Emily C Graff
B Douglas White
Robert L Judd

To determine the effects of niacin on adiponectin and markers of adipose tissue inflammation in a mo...

Remodeling of the HDL in NIDDM: a fundamental role for cholesteryl ester transfer protein.

Castle, C K
Kuiper, S L
Blake, W L
Paigen, B
Marotti, K R
Melchior, G W

January 1998

When the Ay gene is expressed in KK mice, the yellow offspring (KKAy mice) become obese, insulin res...

Niacin inhibits skin dendritic cell mobilization in a GPR109A independent manner but has no impact on monocyte trafficking in atherosclerosis

Ingersoll, Molly A
Potteaux, Stephane
Alvarez, David
Hutchison, Susan B
van Rooijen, Nico
Randolph, Gwendalyn J

May 2012

International audienceHigh-dose niacin therapy in humans reduces mortality from cardiovascular disea...

Pleiotropic effects of niacin: Current possibilities for its clinical use

Zeman Miroslav
Vecka Marek
Perlík František
Staňková Barbora
Hromádka Robert
Tvrzická Eva
Širc Jakub
Hrib Jakub
Žák Aleš

December 2016

Niacin was the first hypolipidemic drug to significantly reduce both major cardiovascular events and...

Niacin in cardiovascular disease: Recent preclinical and clinical developments

Digby, JE
Ruparelia, N
Choudhury, RP

March 2012

Niacin has been used for more than 50 years in the treatment of cardiovascular disease, although its...

Open Access Niacin Modulates Pro-inflammatory Cytokine Secretion. A Potential Mechanism Involved in its Anti-atherosclerotic Effect

Pedro Saul Lipszyca
Graciela Alicia Cremaschib
María Zorrilla Zubiletea
Maria Laura Aón
Francisco Capanic
Ana Maria Genaroa
Miriam Ruth Walda

October 2016

Abstract: The pathogenesis of atherosclerosis includes the assignment of a critical role to cells of...

APOE*3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome

Hoek, A.M. van den
Hoorn, J.W.A. van der
Maas, A.C.
Hoogen, R.M. van den
Nieuwkoop, A. van
Droog, S.
Offerman, E.H.
Pieterman, E.J.
Havekes, L.M.
Princen, H.M.G.

January 2014

Aims: This study aimed to investigate systematically (i) the appropriate dietary conditions to induc...

Niacin: Does It affect 8-hydroxy-2-deoxyguanosine levels of the patients having low HDL cholesterol levels?

Ece Harman
Serkan Akcay
Yanki Buke
Hakan Er

June 2013

We aimed to determine whether niacin improve plasma HDL-cholesterol levels by decreasing 8-Hydroxyde...

Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice

van der Hoorn, José W A
de Haan, Willeke
Berbée, Jimmy F P
Havekes, Louis M
Jukema, J Wouter
Rensen, Patrick C N
Princen, Hans M G

November 2008

Niacin potently decreases plasma triglycerides and LDL-cholesterol. In addition, niacin is the most ...

Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice

Li, Z.
Wang, Y.
Sluis, R.J. van der
Hoorn, J.W.A. van der
Princen, H.M.G.
Eck, M. van
Berkel, T.J.C. van
Rensen, P.C.N.
Hoekstra, M.

January 2012

The anti-dyslipidemic drug niacin has recently been shown to reduce the hepatic expression and plasm...

Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol

Kühnast Susan
Louwe Mieke C.
Heemskerk Mattijs M.
Pieterman Elsbet J.
van Klinken Jan B.
van den Berg Sjoerd A. A.
Smit Johannes W. A.
Havekes Louis M.
Rensen Patrick C. N.
van der Hoorn José W. A.
Princen Hans M. G.
Jukema J. Wouter

June 2013

Niacin potently lowers triglycerides, mildly decreases LDL-cholesterol, and largely increases HDL-ch...

Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-

Mieke C. Louwe
Mattijs M. Heemskerk
Elsbet J. Pieterman
Jan B. Van
Johannes W. A. Smit
Louis M. Havekes
Patrick C. N. Rensen
Hans M. G. Princen
J. Wouter Jukema

August 2016

Objective: Niacin potently lowers triglycerides, mildly decreases LDL-cholesterol, and largely incre...

Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol.

Susan Kühnast
Mieke C Louwe
Mattijs M Heemskerk
Elsbet J Pieterman
Jan B van Klinken
Sjoerd A A van den Berg
Johannes W A Smit
Louis M Havekes
Patrick C N Rensen
José W A van der Hoorn
Hans M G Princen
J Wouter Jukema

Niacin potently lowers triglycerides, mildly decreases LDL-cholesterol, and largely increases HDL-ch...

Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice

de Haan, Willeke
van der Hoogt, Caroline C
Westerterp, Marit
Hoekstra, Menno
Dallinga-Thie, Geesje M
Princen, Hans M G
Romijn, Johannes A
Jukema, J Wouter
Havekes, Louis M
Rensen, Patrick C N

March 2008

In addition to lowering low-density lipoprotein (LDL)-cholesterol, statins modestly increase high-de...

Niacin Increases Adiponectin and Decreases Adipose Tissue Inflammation in High Fat Diet-Fed Mice

Wanders Desiree
Graff Emily C.
White B. Douglas
Judd Robert L.

August 2013

To determine the effects of niacin on adiponectin and markers of adipose tissue inflammation in a mo...

Niacin increases adiponectin and decreases adipose tissue inflammation in high fat diet-fed mice.

Desiree Wanders
Emily C Graff
B Douglas White
Robert L Judd

To determine the effects of niacin on adiponectin and markers of adipose tissue inflammation in a mo...

Remodeling of the HDL in NIDDM: a fundamental role for cholesteryl ester transfer protein.

Castle, C K
Kuiper, S L
Blake, W L
Paigen, B
Marotti, K R
Melchior, G W

January 1998

When the Ay gene is expressed in KK mice, the yellow offspring (KKAy mice) become obese, insulin res...

Niacin inhibits skin dendritic cell mobilization in a GPR109A independent manner but has no impact on monocyte trafficking in atherosclerosis

Ingersoll, Molly A
Potteaux, Stephane
Alvarez, David
Hutchison, Susan B
van Rooijen, Nico
Randolph, Gwendalyn J

May 2012

International audienceHigh-dose niacin therapy in humans reduces mortality from cardiovascular disea...

Pleiotropic effects of niacin: Current possibilities for its clinical use

Zeman Miroslav
Vecka Marek
Perlík František
Staňková Barbora
Hromádka Robert
Tvrzická Eva
Širc Jakub
Hrib Jakub
Žák Aleš

December 2016

Niacin was the first hypolipidemic drug to significantly reduce both major cardiovascular events and...

Niacin in cardiovascular disease: Recent preclinical and clinical developments

Digby, JE
Ruparelia, N
Choudhury, RP

March 2012

Niacin has been used for more than 50 years in the treatment of cardiovascular disease, although its...

Open Access Niacin Modulates Pro-inflammatory Cytokine Secretion. A Potential Mechanism Involved in its Anti-atherosclerotic Effect

Pedro Saul Lipszyca
Graciela Alicia Cremaschib
María Zorrilla Zubiletea
Maria Laura Aón
Francisco Capanic
Ana Maria Genaroa
Miriam Ruth Walda

October 2016

Abstract: The pathogenesis of atherosclerosis includes the assignment of a critical role to cells of...

APOE*3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome

Hoek, A.M. van den
Hoorn, J.W.A. van der
Maas, A.C.
Hoogen, R.M. van den
Nieuwkoop, A. van
Droog, S.
Offerman, E.H.
Pieterman, E.J.
Havekes, L.M.
Princen, H.M.G.

January 2014

Aims: This study aimed to investigate systematically (i) the appropriate dietary conditions to induc...

Niacin: Does It affect 8-hydroxy-2-deoxyguanosine levels of the patients having low HDL cholesterol levels?

Ece Harman
Serkan Akcay
Yanki Buke
Hakan Er

June 2013

We aimed to determine whether niacin improve plasma HDL-cholesterol levels by decreasing 8-Hydroxyde...

Niacin Increases HDL by Reducing Hepatic Expression and Plasma Levels of Cholesteryl Ester Transfer Protein in APOE*3Leiden.CETP Mice

Abstract

Extracted data

Niacin Increases HDL by Reducing Hepatic Expression and Plasma Levels of Cholesteryl Ester Transfer Protein in APOE*3Leiden.CETP Mice

Abstract

Extracted data

Related items

Related items